HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,568,027 | -8.9% | 151,463 | -13.4% | 0.66% | +0.9% |
| Q2 2023 | $14,886,729 | +3.1% | 174,850 | +0.2% | 0.65% | -5.9% |
| Q1 2023 | $14,438,137 | +4.2% | 174,479 | -1.0% | 0.69% | +3.3% |
| Q4 2022 | $13,856,085 | -41.7% | 176,174 | -45.2% | 0.67% | -45.4% |
| Q3 2022 | $23,784,000 | +13.6% | 321,271 | +0.0% | 1.23% | +14.0% |
| Q2 2022 | $20,935,000 | +23.8% | 321,182 | +20.0% | 1.08% | +66.8% |
| Q1 2022 | $16,914,000 | +115.0% | 267,548 | +204.6% | 0.64% | +88.0% |
| Q2 2020 | $7,867,000 | -71.2% | 87,835 | -68.0% | 0.34% | -78.3% |
| Q1 2020 | $27,322,000 | -4.3% | 274,150 | +10.3% | 1.58% | +31.0% |
| Q4 2019 | $28,555,000 | +11.2% | 248,520 | +22.0% | 1.21% | +0.5% |
| Q3 2019 | $25,687,000 | +17.8% | 203,640 | +12.4% | 1.20% | +37.0% |
| Q2 2019 | $21,802,000 | +59.0% | 181,170 | +15.6% | 0.88% | +57.0% |
| Q1 2019 | $13,713,000 | +6.6% | 156,760 | +21.9% | 0.56% | -11.8% |
| Q4 2018 | $12,867,000 | – | 128,607 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |